Literature DB >> 8103822

Insulin-mediated vasodilation: impairment with increased blood pressure and body mass.

R D Feldman1, G S Bierbrier.   

Abstract

Insulin resistance is associated with hypertension although it is not known if this relationship is casual. Studies have shown that insulin increases skeletal-muscle blood flow despite also increasing sympathetic activity. To determine whether insulin may act as a direct vasodilator and whether insulin-mediated vascular effects are altered in hypertension, we studied insulin-mediated alterations in dorsal-hand-vein compliance in normotensive and mild and borderline hypertensive subjects. In phenylephrine pre-constricted vessels, insulin caused a dose-dependent increase in venous distensibility. Insulin-mediated venodilation was significantly impaired in hypertensive subjects. The vasodilator potency of insulin was significantly correlated with both blood pressure and body mass index. Insulin may be an endogenous vasodilator. Further, in hypertensive and obese subjects, impairment of insulin-mediated vasodilation may contribute to the increase in peripheral resistance characteristic of hypertension.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8103822     DOI: 10.1016/0140-6736(93)91708-t

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  19 in total

1.  Myocardial insulin resistance in patients with syndrome X.

Authors:  H E Botker; N Moller; O Schmitz; J P Bagger; T T Nielsen
Journal:  J Clin Invest       Date:  1997-10-15       Impact factor: 14.808

2.  Dietary Polysaccharides in the Amelioration of Gut Microbiome Dysbiosis and Metabolic Diseases.

Authors:  Shokouh Ahmadi; Rabina Mainali; Ravinder Nagpal; Mahmoud Sheikh-Zeinoddin; Sabihe Soleimanian-Zad; Shaohua Wang; Gagan Deep; Santosh Kumar Mishra; Hariom Yadav
Journal:  Obes Control Ther       Date:  2017-12-18

Review 3.  Clinical pharmacology, physiology and pathophysiology of superficial veins--2.

Authors:  W H Aellig
Journal:  Br J Clin Pharmacol       Date:  1994-10       Impact factor: 4.335

Review 4.  Update on G-protein polymorphisms in hypertension.

Authors:  Haidong Zhu; Xiaoling Wang; Yanhui Lu; Joseph Poola; Zamena Momin; Gregory A Harshfield; Harold Snieder; Yanbin Dong
Journal:  Curr Hypertens Rep       Date:  2006-04       Impact factor: 5.369

5.  Effect of insulin on renal sodium handling and renal haemodynamics in insulin-dependent (type 1) diabetes mellitus patients.

Authors:  P Stenvinkel; A Ottosson-Seeberger; A Alvestrand; J Bolinder
Journal:  Acta Diabetol       Date:  1995-12       Impact factor: 4.280

Review 6.  Vascular reactivity in diabetes mellitus.

Authors:  Ajay Chaudhuri
Journal:  Curr Diab Rep       Date:  2002-08       Impact factor: 4.810

7.  Insulin resistance in relatives of NIDDM patients: the role of physical fitness and muscle metabolism.

Authors:  B Nyholm; A Mengel; S Nielsen; C Skjaerbaek; N Møller; K G Alberti; O Schmitz
Journal:  Diabetologia       Date:  1996-07       Impact factor: 10.122

8.  Hypertension and overweight associated with hyperinsulinaemia and glucose tolerance: a longitudinal study of the Finnish and Dutch cohorts of the Seven Countries Study.

Authors:  E J Feskens; J Tuomilehto; J H Stengård; J Pekkanen; A Nissinen; D Kromhout
Journal:  Diabetologia       Date:  1995-07       Impact factor: 10.122

9.  Direct and sympathetically mediated venoconstriction in essential hypertension. Enhanced responses to endothelin-1.

Authors:  W G Haynes; M F Hand; H A Johnstone; P L Padfield; D J Webb
Journal:  J Clin Invest       Date:  1994-10       Impact factor: 14.808

10.  Sex-specific action of insulin to acutely increase the metabolic clearance rate of dehydroepiandrosterone in humans.

Authors:  J E Nestler; Z Kahwash
Journal:  J Clin Invest       Date:  1994-10       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.